Human β-cell proliferation and intracellular signaling part 2: Still driving in the dark without a road map

Diabetes

Volumn 63, Issue 3, 2014, Pages 819-831

  Bernal Mizrachi, Ernesto ^a   Kulkarni, Rohit N ^b   Scott, Donald K ^c   Mauvais Jarvis, Franck ^d   Stewart, Andrew F ^c   Garcia Ocaña, Adolfo ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMP-ACTIVATED PROTEIN KINASES; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL PROLIFERATION; DIABETES MELLITUS; ESTROGENS; GLUCOSE; HUMANS; INSULIN-SECRETING CELLS; LEPTIN; NFATC TRANSCRIPTION FACTORS; PROGESTERONE; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

EID: 84894454462     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1146     Document Type: Review

References (94)

1. Kulkarni RN, Mizrachi E-B, Ocana AG, Stewart AF. Human b-cell proliferation and intracellular signaling: driving in the dark without a road map. Diabetes 2012;61:2205-2213
2. Porat S, Weinberg-Corem N, Tornovsky-Babaey S, et al. Control of pancreatic b cell regeneration by glucose metabolism. Cell Metab 2011;13: 440-449
3. Nakamura A, Terauchi Y, Ohyama S, et al. Impact of small-molecule glucokinase activator on glucose metabolism and beta-cell mass. Endocrinology 2009;150:1147-1154
4. Guillam MT, Hümmler E, Schaerer E, et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2 [published correction appears in Nat Genet 1997;17:503]. Nat Genet 1997;17:327-330
5. De Vos A, Heimberg H, Quartier E, et al. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 1995;96:2489-2495
6. Kassem S, Bhandari S, Rodríguez-Bada P, et al. Large islets, beta-cell proliferation, and a glucokinase mutation. N Engl J Med 2010;362:1348-1350
7. Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci USA 2004;101:7281-7286
8. Davies MN, O'Callaghan BL, Towle HC. Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity. J Biol Chem 2008;283:24029-24038
9. Kabashima T, Kawaguchi T, Wadzinski BE, Uyeda K. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci USA 2003;100:5107-5112
10. Ma L, Robinson LN, Towle HC. ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver. J Biol Chem 2006;281: 28721-28730
11. Herman MA, Peroni OD, Villoria J, et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 2012;484:333-338
12. Eissing L, Scherer T, Tödter K, et al. De novo lipogenesis in human fat and liver is linked to ChREBP-b and metabolic health. Nat Commun 2013;4:1528
13. Kursawe R, Caprio S, Giannini C, et al. Decreased transcription of ChREBPa/ b isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia. Diabetes 2013;62:837-844
14. Metukuri MR, Zhang P, Basantani MK, et al. ChREBP mediates glucosestimulated pancreatic b-cell proliferation. Diabetes 2012;61:2004-2015
15. Poungvarin N, Lee JK, Yechoor VK, et al. Carbohydrate response elementbinding protein (ChREBP) plays a pivotal role in beta cell glucotoxicity. Diabetologia 2012;55:1783-1796
16. Vaahtomeri K, Mäkelä TP. Molecular mechanisms of tumor suppression by LKB1. FEBS Lett 2011;585:944-951
17. Corradetti MN, Inoki K, Bardeesy N, DePinho RA, Guan KL. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev 2004;18: 1533-1538
18. Shaw RJ, Lamia KA, Vasquez D, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005; 310:1642-1646
19. Ylipaasto P, Kutlu B, Rasilainen S, et al. Global profiling of coxsackievirusand cytokine-induced gene expression in human pancreatic islets. Diabetologia 2005;48:1510-1522
20. Fu A, Ng AC-H, Depatie C, et al. Loss of Lkb1 in adult beta cells increases beta cell mass and enhances glucose tolerance in mice. Cell Metab 2009; 10:285-295
21. Granot Z, Swisa A, Magenheim J, et al. LKB1 regulates pancreatic beta cell size, polarity, and function. Cell Metab 2009;10:296-308
22. Sun G, Tarasov AI, McGinty JA, et al. LKB1 deletion with the RIP2.Cre transgene modifies pancreatic beta-cell morphology and enhances insulin secretion in vivo. Am J Physiol Endocrinol Metab 2010;298:E1261-E1273
23. Sun G, Tarasov AI, McGinty J, et al. Ablation of AMP-activated protein kinase alpha1 and alpha2 from mouse pancreatic beta cells and RIP2.Cre neurons suppresses insulin release in vivo. Diabetologia 2010;53:924-936
24. Leclerc I, Woltersdorf WW, da Silva Xavier G, et al. Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab 2004;286:E1023-E1031
25. Demozay D, Tsunekawa S, Briaud I, Shah R, Rhodes CJ. Specific glucoseinduced control of insulin receptor substrate-2 expression is mediated via Ca2+-dependent calcineurin/NFAT signaling in primary pancreatic islet b-cells. Diabetes 2011;60:2892-2902
26. Goodyer WR, Gu X, Liu Y, Bottino R, Crabtree GR, Kim SK. Neonatal b cell development in mice and humans is regulated by calcineurin/NFAT. Dev Cell 2012;23:21-34
27. Hardie DG. Signal transduction: How cells sense energy. Nature 2011;472: 176-177
28. Heit JJ, Apelqvist AA, Gu X, et al. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 2006;443:345-349
29. Kahl CR, Means AR. Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 2003;24:719-736
30. Nguidjoe E, Sokolow S, Bigabwa S, et al. Heterozygous inactivation of the Na/Ca exchanger increases glucose-induced insulin release, b-cell proliferation, and mass. Diabetes 2011;60:2076-2085
31. Salpeter SJ, Klochendler A, Weinberg-Corem N, et al. Glucose regulates cyclin D2 expression in quiescent and replicating pancreatic b-cells through glycolysis and calcium channels. Endocrinology 2011;152:2589-2598
32. Jansson D, Ng AC, Fu A, Depatie C, Al Azzabi M, Screaton RA. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc Natl Acad Sci USA 2008;105:10161-10166
33. Song WJ, Schreiber WE, Zhong E, et al. Exendin-4 stimulation of cyclin A2 in beta-cell proliferation. Diabetes 2008;57:2371-2381
34. Lawrence MC, Naziruddin B, Levy MF, Jackson A, McGlynn K. Calcineurin/ nuclear factor of activated T cells and MAPK signaling induce TNF-alpha gene expression in pancreatic islet endocrine cells. J Biol Chem 2011;286: 1025-1036
35. Soltani N, Qiu H, Aleksic M, et al. GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proc Natl Acad Sci USA 2011;108:11692-11697
36. Lopez-Talavera JC, Garcia-Ocaña A, Sipula I, Takane KK, Cozar-Castellano I, Stewart AF. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. Endocrinology 2004;145:467-474
37. Weir MR, Fink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999;34:1-13
38. Shing Y, Christofori G, Hanahan D, et al. Betacellulin: a mitogen from pancreatic beta cell tumors. Science 1993;259:1604-1607
39. Huotari MA, Palgi J, Otonkoski T. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen. Endocrinology 1998;139:1494-1499
40. Li L, Seno M, Yamada H, Kojima I. Promotion of beta-cell regeneration by betacellulin in ninety percent-pancreatectomized rats. Endocrinology 2001; 142:5379-5385
41. Tokui Y, Kozawa J, Yamagata K, et al. Neogenesis and proliferation of beta-cells induced by human betacellulin gene transduction via retrograde pancreatic duct injection of an adenovirus vector. Biochem Biophys Res Commun 2006;350:987-993
42. Oh YS, Shin S, Lee YJ, Kim EH, Jun HS. Betacellulin-induced beta cell proliferation and regeneration is mediated by activation of ErbB-1 and ErbB-2 receptors. PLoS One 2011;6:e23894
43. Hakonen E, Ustinov J, Mathijs I, et al. Epidermal growth factor (EGF)-receptor signalling is needed for murine beta cell mass expansion in response to high-fat diet and pregnancy but not after pancreatic duct ligation. Diabetologia 2011;54:1735-1743
44. Miettinen PJ, Huotari M, Koivisto T, et al. Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors. Development 2000;127:2617-2627
45. Miettinen PJ, Ustinov J, Ormio P, et al. Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal beta-cell growth. Diabetes 2006;55:3299-3308
46. Krakowski ML, Kritzik MR, Jones EM, et al. Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes. J Endocrinol 1999;162:167-175
47. Means AL, Ray KC, Singh AB, et al. Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. Gastroenterology 2003;124:1020-1036
48. Kuntz E, Broca C, Komurasaki T, et al. Effect of epiregulin on pancreatic beta cell growth and insulin secretion. Growth Factors 2005;23:285-293
49. Mares J, Claesson-Welsh L, Welsh M. A chimera between platelet-derived growth factor beta-receptor and fibroblast growth factor receptor-1 stimulates pancreatic beta-cell DNA synthesis in the presence of PDGF-BB. Growth Factors 1992;6:93-101
50. Welsh M, Claesson-Welsh L, Hallberg A, et al. Coexpression of the plateletderived growth factor (PDGF) B chain and the PDGF beta receptor in isolated pancreatic islet cells stimulates DNA synthesis. Proc Natl Acad Sci USA 1990;87:5807-5811
51. Chen H, Gu X, Liu Y, et al. PDGF signalling controls age-dependent proliferation in pancreatic b-cells. Nature 2011;478:349-355
52. Miyagawa J, Hanafusa O, Sasada R, et al. Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells. Endocr J 1999;46:755-764
53. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004;303:1483-1487
54. Nusse R. Wnt signaling in disease and in development. Cell Res 2005;15: 28-32
55. Welters HJ, Kulkarni RN. Wnt signaling: relevance to beta-cell biology and diabetes. Trends Endocrinol Metab 2008;19:349-355
56. Liu Z, Habener JF. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J Biol Chem 2008;283:8723-8735
57. Dabernat S, Secrest P, Peuchant E, Moreau-Gaudry F, Dubus P, Sarvetnick N. Lack of beta-catenin in early life induces abnormal glucose homeostasis in mice. Diabetologia 2009;52:1608-1617
58. Murtaugh LC, Law AC, Dor Y, Melton DA. Beta-catenin is essential for pancreatic acinar but not islet development. Development 2005;132: 4663-4674
59. Papadopoulou S, Edlund H. Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function. Diabetes 2005;54:2844-2851
60. Heiser PW, Lau J, Taketo MM, Herrera PL, Hebrok M. Stabilization of betacatenin impacts pancreas growth. Development 2006;133:2023-2032
61. Wells JM, Esni F, Boivin GP, et al. Wnt/beta-catenin signaling is required for development of the exocrine pancreas. BMC Dev Biol 2007;7:4
62. Dessimoz J, Bonnard C, Huelsken J, Grapin-Botton A. Pancreas-specific deletion of beta-catenin reveals Wnt-dependent and Wnt-independent functions during development. Curr Biol 2005;15:1677-1683
63. Rulifson IC, Karnik SK, Heiser PW, et al. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci USA 2007;104:6247-6252
64. Elghazi L, Gould AP, Weiss AJ, et al. Importance of b-catenin in glucose and energy homeostasis. Sci Rep 2012;2:693
65. da Silva Xavier G, Mondragon A, Sun G, et al. Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice. Diabetologia 2012;55:2667-2676
66. Boj SF, van Es JH, Huch M, et al. Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 2012;151:1595-1607
67. Figeac F, Uzan B, Faro M, Chelali N, Portha B, Movassat J. Neonatal growth and regeneration of beta-cells are regulated by the Wnt/beta-catenin signaling in normal and diabetic rats. Am J Physiol Endocrinol Metab 2010; 298:E245-E256
68. Shu L, Zien K, Gutjahr G, et al. TCF7L2 promotes beta cell regeneration in human and mouse pancreas. Diabetologia 2012;55:3296-3307
69. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J, Maedler K. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 2008;57:645-653
70. Kieffer TJ, Heller RS, Habener JF. Leptin receptors expressed on pancreatic beta-cells. Biochem Biophys Res Commun 1996;224:522-527
71. Kulkarni RN, Wang ZL, Wang RM, et al. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 1997;100:2729-2736
72. Emilsson V, Liu YL, Cawthorne MA, Morton NM, Davenport M. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997;46:313-316
73. Morioka T, Asilmaz E, Hu J, et al. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest 2007;117:2860-2868
74. Covey SD, Wideman RD, McDonald C, et al. The pancreatic beta cell is a key site for mediating the effects of leptin on glucose homeostasis. Cell Metab 2006;4:291-302
75. Jetton TL, Lausier J, LaRock K, et al. Mechanisms of compensatory betacell growth in insulin-resistant rats: roles of Akt kinase. Diabetes 2005;54: 2294-2304
76. Seufert J, Kieffer TJ, Leech CA, et al. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus. J Clin Endocrinol Metab 1999;84:670-676
77. Lee YH, Magkos F, Mantzoros CS, Kang ES. Effects of leptin and adiponectin on pancreatic b-cell function. Metabolism 2011;60:1664-1672
78. Tiano JP, Mauvais-Jarvis F. Importance of oestrogen receptors to preserve functional b-cell mass in diabetes. Nat Rev Endocrinol 2012;8:342-351
79. Houssay BA, Foglia VG, Rodriguez RR. Production or prevention of some types of experimental diabetes by oestrogens or corticosteroids. Acta Endocrinol (Copenh) 1954;17:146-164
80. Goodman MN, Hazelwood RL. Short-term effects of oestradiol benzoate in normal, hypophysectomized and alloxan-diabetic male rats. J Endocrinol 1974;62:439-449
81. Sorenson RL, Brelje TC, Roth C. Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy. Endocrinology 1993;133: 2227-2234
82. Choi SB, Jang JS, Park S. Estrogen and exercise may enhance beta-cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats. Endocrinology 2005;146:4786-4794
83. Le May C, Chu K, Hu M, et al. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA 2006;103:9232-9237
84. Liu S, Kilic G, Meyers MS, et al. Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetes. Diabetologia 2013;56:370-381
85. Tiano JP, Delghingaro-Augusto V, Le May C, et al. Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents b cell failure in rodent models of type 2 diabetes. J Clin Invest 2011;121:3331-3342
86. Wong WP, Tiano JP, Liu S, et al. Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc Natl Acad Sci USA 2010;107:13057-13062
87. Tiano JP, Mauvais-Jarvis F. Molecular mechanisms of estrogen receptors' suppression of lipogenesis in pancreatic b-cells. Endocrinology 2012;153: 2997-3005
88. Jacovetti C, Abderrahmani A, Parnaud G, et al. MicroRNAs contribute to compensatory b cell expansion during pregnancy and obesity. J Clin Invest 2012;122:3541-3551
89. Kumar R, Balhuizen A, Amisten S, Lundquist I, Salehi A. Insulinotropic and antidiabetic effects of 17b-estradiol and the GPR30 agonist G-1 on human pancreatic islets. Endocrinology 2011;152:2568-2579
90. Liu S, Le May C, Wong WP, et al. Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 2009;58:2292-2302
91. Ren Z, Zou C, Ji H, Zhang YA. Oestrogen regulates proliferation and differentiation of human islet-derived precursor cells through oestrogen receptor alpha. Cell Biol Int 2010;34:523-530
92. Nieuwenhuizen AG, Schuiling GA, Liem SM, Moes H, Koiter TR, Uilenbroek JT. Progesterone stimulates pancreatic cell proliferation in vivo. Eur J Endocrinol 1999;140:256-263
93. Picard F, Wanatabe M, Schoonjans K, Lydon J, O'Malley BW, Auwerx J. Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta-cell proliferation. Proc Natl Acad Sci USA 2002; 99:15644-15648
94. Doglioni C, Gambacorta M, Zamboni G, Coggi G, Viale G. Immunocytochemical localization of progesterone receptors in endocrine cells of the human pancreas. Am J Pathol 1990;137:999-1005 Diseases Diseases Diseases Diseases Diseases